The splanchnic pharmacodynamic effects of the drugs used for the treatment
of hemorrhagic complications of portal hypertension were poorly clarified u
ntil some years ago. The introduction of Doppler ultrasound provided a powe
rful tool to investigate such hemodynamic effects and brought new insights
in this field. The present article reviews the pharmacodynamics of the subs
tances used in the treatment of portal hypertension, with particular regard
to the effects assessable by duplex Doppler ultrasonography. (C) 1999 Worl
d Federation for Ultrasound in Medicine & Biology.